NORTHERN TRUST CORP - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 44 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$60,226
+206.7%
101,887
+102.2%
0.00%
Q4 2022$19,638
-27.3%
50,380
-0.0%
0.00%
Q3 2022$27,000
-30.8%
50,383
+103.3%
0.00%
Q2 2022$39,00024,7860.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 14$170.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders